BioMap

About BioMap

BioMap is a pioneering startup that operates in the life sciences sector, leveraging artificial intelligence (AI) to understand and predict biological behavior at various levels of complexity. The company's primary offering is its AI Foundation Models, which are designed to generate diverse proteins quickly and accurately, even with limited labeled data. This is a significant departure from traditional AI methods, which typically require large amounts of labeled data to make accurate predictions.

BioMap's flagship model, xTrimo, is a pre-trained large language model that has been trained on the company's proprietary datasets. These datasets include more than 6 billion proteins, 100 billion protein-protein interactions, and trillions of single-cell gene expression measurements from over 100 million cells. This makes xTrimo the largest life science AI Foundation Model to date, boasting over 100 billion parameters.

The company's business model revolves around partnering with global leaders from academia and industry to maximize the potential of its foundation and task models. Together, they innovate solutions to create better, more powerful proteins. BioMap has also launched the Life Science Leaderboard, a tool that allows users to find and evaluate the performance of various task models for life science.

BioMap operates in a niche market, serving clients in the life sciences sector who are interested in leveraging AI for protein generation and other biological applications. The company generates revenue through partnerships and collaborations with these clients, as well as through the use of its Life Science Leaderboard tool.